191 related articles for article (PubMed ID: 13270267)
21. Toxicity and anti-leukaemic effectiveness, in mice, of 4-amino-4-deoxy-N(10)-methyl-5,6,7,8-tetrahydropteroylglutamic acid (tetrahydroamethopterin).
MEAD JA; VENDITTI JM; SCHRECKER AW; GOLDIN A; KISLIUK RL
Nature; 1961 Mar; 189():937-9. PubMed ID: 13768769
[No Abstract] [Full Text] [Related]
22. A DIRECT ASSAY FOR DIHYDROFOLATE REDUCTASE IN HUMAN LEUKOCYTES.
MISRA DK
Blood; 1964 May; 23():572-80. PubMed ID: 14142499
[No Abstract] [Full Text] [Related]
23. Effect of orally administered 3', 5'-dichloroamethopterin on formate-C14 incorporation in leukemic mice.
SCHRECKER AW; MEAD JA; LYNCH MR; VENDITTI JM; GOLDIN A
Cancer Res; 1960 Nov; 20():1457-61. PubMed ID: 13748581
[No Abstract] [Full Text] [Related]
24. Studies on inhibiting effect of aminopterin and other folic acid antagonist, and folic acid upon the Yoshida sarcoma.
ASANO T
Tohoku J Exp Med; 1953 Feb; 57(2-3):221-5. PubMed ID: 13090205
[No Abstract] [Full Text] [Related]
25. Studies on the folic acid vitamins. III. The duration of the effects of the folic acid antagonists in man.
CONDIT PT
Cancer; 1960; 13():229-35. PubMed ID: 13811475
[No Abstract] [Full Text] [Related]
26. Incorporation of formate-C-14 in normal and leukemic mice during extended treatment with amethopterin and 3',5'-dichloramethopterin.
SCHRECKER AW; MEAD JA; GOLDIN A
Cancer Res; 1962 Jan; 22():15-20. PubMed ID: 13909245
[No Abstract] [Full Text] [Related]
27. [Does folic acid encourage tumor growth?].
Begemann H
Munch Med Wochenschr; 1969 Jan; 111(1):62. PubMed ID: 5818694
[No Abstract] [Full Text] [Related]
28. Inhibition of the growth of an ame-thopterin-refractory tumor by dietary restriction of folic acid.
ROSEN F; NICHOL CA
Cancer Res; 1962 May; 22():495-500. PubMed ID: 14493889
[No Abstract] [Full Text] [Related]
29. [Acute leukemia and folic acid antagonists].
DUBOIS-FERRIERE H
Sang; 1950; 21(4):372-5. PubMed ID: 15430935
[No Abstract] [Full Text] [Related]
30. The effect of combined irradiation and chemotherapy on cancer growth with special reference to studies with folic acid analogues.
LOKEN MK; KIM YS; MOSSER DG; MARVIN JF
Radiology; 1959 Aug; 73():166-74. PubMed ID: 14418029
[No Abstract] [Full Text] [Related]
31. The treatment of acute leukemia with folic acid antagonists.
STICKNEY JM; MILLS SD
Proc Staff Meet Mayo Clin; 1949 Oct; 24(21):525-33. PubMed ID: 18142818
[No Abstract] [Full Text] [Related]
32. Treatment of leukemia in children with folic acid antagonists.
RICE EC; CASSIDY JE; LEYVA FR; CROWELL WM; JUDGE DF; TROENDLE FJ; VADEN EB
Clin Proc Child Hosp Dist Columbia; 1950 Aug; 6(9):267-77. PubMed ID: 15434962
[No Abstract] [Full Text] [Related]
33. A comparison of 4-amino-4-deoxy-N10-methylpteroic acid and methotrexate transport by mouse leukemia cells.
Kessel D
Mol Pharmacol; 1969 Jan; 5(1):21-5. PubMed ID: 5392912
[No Abstract] [Full Text] [Related]
34. [Folic acid, its antagonists, B12, animal protein factor and its importance for animal and human organism].
ZINK A
Int Z Vitaminforsch Beih; 1952; 23(4):471-84. PubMed ID: 14937893
[No Abstract] [Full Text] [Related]
35. [Folic acid antagonist in microbiologic experiment].
PERSHIN GN; DOLGUSHEVA AN
Biokhimiia; 1952; 17(3):339-42. PubMed ID: 13081626
[No Abstract] [Full Text] [Related]
36. Evaluation of X-methyl folate preparations as possible folic acid antagonists.
Waxman S; Schreiber C; Waxman S
Chemotherapy; 1982; 28(5):402-9. PubMed ID: 7140422
[TBL] [Abstract][Full Text] [Related]
37. The growth of Rous sarcoma in folic acid deficient chicks.
ENGELBRETH-HOLM J; RASK-NIELSEN R; HOFF-JØRGENSEN E; KALCKAR H
Acta Pathol Microbiol Scand; 1951; 29(1):84-95. PubMed ID: 14902463
[No Abstract] [Full Text] [Related]
38. Treatment of leukemia and allied disorders with folic acid antagonists, effect of aminopterin on skeletal lesions.
SILVERMAN FN
Radiology; 1950 May; 54(5):665-78. PubMed ID: 15417758
[No Abstract] [Full Text] [Related]
39. Cytotoxic mechanisms of folate antagonists.
Borsa J
Ann N Y Acad Sci; 1971 Nov; 186():359-62. PubMed ID: 5289426
[No Abstract] [Full Text] [Related]
40. [Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].
MATHE G; AMIEL JL; NIEMETZ J
C R Hebd Seances Acad Sci; 1962 May; 254():3603-5. PubMed ID: 14471072
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
